Master Rollover Protocol for Continued Safety Assessment of Study Drug
2 other identifiers
expanded_access
N/A
1 country
3
Brief Summary
This study is for patients who have participated in a previous study and who continue to receive benefit to have continued access to study drug and/or treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 15, 2015
CompletedFirst Posted
Study publicly available on registry
December 17, 2015
CompletedSeptember 29, 2025
September 1, 2025
December 15, 2015
September 26, 2025
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- To be eligible patients must be currently receiving benefit in a concluded Lilly study for a compound that has opened an addendum in the continued access protocol.
You may not qualify if:
- Patients must not be concurrently enrolled in any other type of medical research judged not to be scientifically or medically compatible with this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
UCLA Medical Center
Torrance, California, 90505, United States
Fort Wayne Oncology & Hematology
Fort Wayne, Indiana, 46804, United States
Sarah Cannon Cancer Center
Nashville, Tennessee, 37203, United States
MeSH Terms
Conditions
Interventions
Study Officials
- STUDY DIRECTOR
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company
Central Study Contacts
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
CONTACT
Physicians interested in becoming principal investigators please contact
CONTACT
Study Design
- Study Type
- expanded access
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2015
First Posted
December 17, 2015
Last Updated
September 29, 2025
Record last verified: 2025-09